Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Experimental autoimmune encephalomyelitis.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.
White matter disease: Aquaporin-4 antibody-positive patients may not always fulfil the clinical criteria for neuromyelitis optica.
Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.
Acquired Immunologic Neuropathies.
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.
A preliminary study of functional imaging upon placebo analgesia in progressive multiple sclerosis.
Combined central and peripheral demyelination.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
Pharmacology and Structure of P2Y Receptors.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Antiretrovirals inhibit arginase in human microglia.
Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Multiple sclerosis in Japan appears to be a milder disease compared to the UK.
Objectification of psychogenic postural instability by trunk sway analysis.

Pages